Neurocrine Biosciences Inc. (NB3)
Market Closed
17 Jul, 20:00
€
146. 95
-1.65
-1.1104%
€
13.41B Market Cap
63.27 P/E Ratio
- Div Yield
64 Volume
2.29 Eps
€ 148.6
Previous Close Want to track NB3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurocrine Biosciences Inc. (NB3) Statistics
Valuation metrics
Market Cap 13.41B
Enterprise value 10.85B
Trailing P/E (ttm) 24.12
Forward P/E 34.68
PEG ratio 0.01
Price/Sales (ttm) 4.34
Price/Book (mrq) 4.85
Enterprise Value/Revenue 4.06
Enterprise Value/EBITDA 15.21
Overview
Shares outstanding 100.58M
Float 99.26M
Shares short -
% Held by insiders 0.01%
% Held by institutions 1.03%
Average volume (10 days) 60
Average volume (90 days) 47
Price summary
52-Week low 102.55
52-Week high 158.65
Beta 0.34
50-Day moving average 114.12
200-Day moving average 117.77
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.22%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.23%
Income Statement
Revenue (ttm) 2.67B
Revenue per share (ttm) 31.12
Quarterly revenue growth (yoy) 0.42%
Gross profit (ttm) 1.72B
EBITDA 780.2M
Net income to common (ttm) 575.34M
Diluted EPS (ttm) 5.55
Quarterly earnings growth (yoy) 24.05%
Balance Sheet
Total cash (mrq) 1.13B
Total cash per share (mrq) 13.09
Total debt (mrq) 398.85M
Total Debt/Equity (mrq) 13.6
Current ratio (mrq) 2.93%
Book value per share (mrq) 27.62
Cash Flow
Cash flow statement 743.22M
Levered free cash flow (LFCF) 508.17M
